BG
PRTA icon

Bellevue Group’s Prothena Corp PRTA Stock Holding History

Bellevue Group’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,850
Closed -$1.13M – 145
2018
Q1 		$1.13M Sell
30,850
-500
-2% -$18.2K 0.11% 104
2017
Q4 		$1.18M Sell
31,350
-6,050
-16% -$308K 0.12% 105
2017
Q3 		$2.42M Sell
37,400
-3,600
-9% -$221K 0.25% 77
2017
Q2 		$2.22M Hold
41,000
– – 0.26% 77
2017
Q1 		$2.29M Hold
41,000
– – 0.3% 76
2016
Q4 		$2.02M Hold
41,000
– – 0.41% 64
2016
Q3 		$2.46M Buy
41,000
+10,000
+32% +$537K 0.44% 63
2016
Q2 		$1.08M Hold
31,000
– – 0.2% 94
2016
Q1 		$1.28M Buy
+31,000
New +$1.21M 0.23% 90

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group's PRTA Position: Q2 2018 in Review

Bellevue Group sold out of Prothena Corp (PRTA) in Q2 2018, closing a stake of 30,850 shares — an estimated $1.13M sold.

Bellevue Group first reported a position in PRTA in Q1 2016 and held it in 9 quarters. The position peaked at $2.46M in Q3 2016. 125 funds tracked by Wall St. Rank hold PRTA as of Q2 2018.

  • Bellevue Group reported no remaining Prothena Corp position as of Q2 2018 after selling out during the quarter.
  • Bellevue Group sold 30,850 Prothena Corp shares in Q2 2018, an estimated $1.13M.
  • Bellevue Group first reported a position in Prothena Corp in Q1 2016 and held it in 9 quarters.
  • Bellevue Group's Prothena Corp position peaked at $2.46M in Q3 2016.
  • 125 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2018.

Based on Bellevue Group's 13F filing for Q2 2018, filed 7 Aug 2018.